Midi vs Alloy vs Winona vs Evernow: Which Menopause Telehealth Provider Fits You?

Midi, Alloy, Winona, and Evernow are the four online HRT services midlife women bring up most often. The honest answer to “which is best?” is that the question is shaped wrong. Each of these practices is the right answer to a different question, and the most useful comparison is one organized around the patient's situation rather than a ranked list. This page walks through the most common situations and points to the provider whose operating model is calibrated for it.

If you want insurance to pay for the visit

Midiremains the strongest insurance-first option because it markets in-network care with most PPO plans and prices self-pay visits at $250 initial and $150 for continued-care. Evernow now also offers insurance-eligible video visits and membership-based care starting at $35/month, so the distinction is no longer “Midi has insurance and the others do not.” The better distinction is that Midi is built around an insurance-first clinical visit model, while Evernow offers a mix of membership care and optional insurance-eligible video visits. For an insured patient whose first priority is using her coverage, Midi is still the natural starting point; patients who want flexibility between asynchronous messaging and insurance-eligible visits may also consider Evernow.

If your symptoms span more than hot flashes

Alloy is built around the premise that midlife women's-health complaints rarely arrive alone. The annual-membership model unlocks ongoing clinician messaging across HRT and adjacent prescriptions — vaginal symptoms, libido, sleep, hair, skin — under one clinical relationship. Patients should expect to pay the membership plus medication and labs; the value is the coordination, not the unit price.

If you specifically want bioidentical or compounded preparations

Winona has the deepest bioidentical and compounded formulary of the four. The default is FDA-approved transdermal estradiol and oral micronized progesterone, with compounded options available where a clinician judges them appropriate. Patients should understand the difference between FDA-approved bioidentical products and compounded bioidentical preparations before choosing this route; the distinction is real and is covered in our HRT benefits and risks page.

If you are in perimenopause and have been told your labs are normal

Evernow's intake is calibrated for the perimenopausal arc rather than for postmenopause. It uses both cyclic and continuous micronized progesterone where appropriate and recognizes that perimenopausal labs often fluctuate and may not be diagnostic. Care is asynchronous and messaging-based — a fit for patients who value carefully written exchanges and a frustration for patients who specifically want a scheduled video visit.

The 60-second decision frame

• Lowest out-of-pocket, insurance accepted: Midi.
• Coordinated care across midlife symptoms: Alloy.
• Bioidentical and compounded options: Winona.
• Perimenopause specifically, messaging-based care: Evernow.
• Vaginal symptoms only, lowest cost: consider Wisp instead — see the homepage provider comparison.
• Cheapest entry, predictable bundled price: consider Hers instead.

What none of these can do

None of these services can give you a diagnosis or a treatment plan without a clinical encounter. None can guarantee that a particular regimen will resolve your symptoms in a particular timeframe; if a marketing page promises “you will feel better in X days,” treat that as a reason for caution, not confidence. The right hormones, doses, delivery methods, and durations for an individual patient depend on her medical history, her current symptoms, her personal risk profile, and the judgment of a clinician who knows her. This comparison narrows the entry door; it does not replace the conversation behind it.

For the full review of all seven providers we currently cover, see our provider comparison. For cost detail across formulations and provider models, see HRT Cost in 2026.